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BACKGROUND: Actin depolymerizing proteins of the actin depolymerizing factor (ADF)/cofilin family are essential
for actin dynamics, which is critical for synaptic function. Two ADF/cofilin family members, ADF and n-cofilin, are
highly abundant in the brain, where they are present in excitatory synapses. Previous studies demonstrated the
relevance of n-cofilin for postsynaptic plasticity, associative learning, and anxiety. These studies also suggested
overlapping functions for ADF and n-cofilin.
METHODS: We performed pharmacobehavioral, electrophysiologic, and electron microscopic studies on ADF and
n-cofilin single mutants and double mutants (named ACC mice) to characterize the importance of ADF/cofilin activity
for synapse physiology and mouse behavior.
RESULTS: The ACC mice, but not single mutants, exhibited hyperlocomotion, impulsivity, and impaired working
memory. Hyperlocomotion and impulsive behavior were reversed by methylphenidate, a psychostimulant commonly
used for the treatment of attention-deficit/hyperactivity disorder (ADHD). Also, ACC mice displayed a disturbed
morphology of striatal excitatory synapses, accompanied by strongly increased glutamate release. Blockade of
dopamine or glutamate transmission resulted in normal locomotion.
CONCLUSIONS: Our study reveals that ADHD can result from a disturbed balance between excitation and inhibition
in striatal circuits, providing novel insights into the mechanisms underlying this neurobehavioral disorder. Our results
link actin dynamics to ADHD, suggesting that mutations in actin regulatory proteins may contribute to the etiology of
ADHD in humans.
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persistent and maladaptive symptoms of hyperactivity, impul-
sivity, and inattention (1). Among the most common psychi-
atric disorders, ADHD affects approximately 8% of school-age
children worldwide and often persists into adolescence or
adulthood (1,2). Twin, adoption, and segregation studies have
revealed a high heritability of ADHD, and molecular genetics
associated ADHD with dopamine-related genes, including the
dopamine transporter (DAT) and dopamine receptors (3).
Defects reminiscent of ADHD are displayed by DAT mutant
mice, underlining the implication of dopamine dysfunction in
the etiology of ADHD (4). Several ADHD susceptibility loci do
not contain dopamine-related genes (5–9), and an increasing
number of studies implicate corticostriatal network abnormal-
ities in ADHD (10). These findings, together with the pheno-
typic heterogeneity of patients with ADHD, suggest the
existence of diverse ADHD-associated genes and underlying
mechanisms.
Actin is abundant in presynaptic terminals and postsynaptic
spines (11), and numerous studies highlight the relevance of
actin dynamics for postsynaptic plasticity (12). PharmacologicN: 0006-3223 B
SEE COMMENTAstudies and the subsynaptic distribution of actin filaments also
suggest a role for actin in neurotransmitter release (13,14).
Actin depolymerizing proteins of the actin depolymerizing
factor (ADF)/cofilin family are essential regulators of actin
dynamics (15). Two family members, ADF and n-cofilin, are
highly abundant in the adult brain and present in excitatory
synapses (16–18). Analyses of gene-targeted mice revealed
the relevance of n-cofilin for postsynaptic plasticity, learning,
and anxiety (19,20). However, these analyses also suggested
an overlapping function for ADF and n-cofilin.
We report an ADHD-like phenotype in double mutant mice
lacking ADF and n-cofilin (named ACC mice) that lack ADF
systemically and n-cofilin specifically in the adult telencepha-
lon. Neurobehavioral abnormalities included hyperlocomotion,
impulsivity, and impaired working memory. These abnormal-
ities were not present in single mutants. In ACC mice,
locomotion was normalized, and impulsive behavior was
reduced by the ADHD medication methylphenidate (1). We
also found an altered morphology of excitatory synapses and
increased glutamate release in the striatum of ACC mice.
Additionally, locomotion of ACC mice was normalized by& 2015 Society of Biological Psychiatry 95
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enhanced glutamate release caused by impaired actin dynam-
ics results in dopamine deregulation and, ultimately, in an
ADHD-like phenotype.METHODS AND MATERIALS
Mice
Double mutant mice lacking ADF and n-cofilin (ACC mice;
ADF2/2/n-Cofflx/flx,CamKII-cre) were generated by intercrossing
mutants with a single ADF allele and a single floxed n-cofilin
allele (16). One of the breeding animals additionally expressed
Cre recombinase under control of the CaMKIIα promoter (21).
ADF1/1/n-Cofflx/flx mice served as control animals. The
CaMKII-Cre mice were also intercrossed with Rosa26-Cre
reporter mice to determine Cre activity (22). All mice were
housed in the animal facility of the University of Kaiserslautern
on 12-hour dark-light cycles with food and water available ad
libitum. Behavioral experiments were conducted during the
light cycle. Treatment of mice was in accordance with the
German law for conducting animal experiments and followed
the guidelines for the care and use of laboratory animals of the
U.S. National Institutes of Health. Behavioral experiments and
killing of mice for tissue analysis were approved by the Land-
esuntersuchungsamt Rheinland-Pfalz (references: 23177–07/
G09-2-001, 23177-07/G12-2-077, and A2010_01_15UniKL).
Mouse husbandry and breeding was approved by the City of
Kaiserslautern, Referat Umweltschutz.
Behavior
With the exception of home cage behavior, all experiments
were conducted on mice 35–42 days old. A detailed descrip-
tion of the methods is provided in Supplement 1.
Electron Microscopy
Small specimens taken from the striatum (bregma .98–.14) of
male mice 40–42 days old were used for ultrastructure
analyses. Experiments were performed as described previ-
ously (17). Detailed information is provided in Supplement 1.
Histology
Histology was performed on brains from mice 38–40 days old.
Detailed information is provided in Supplement 1.
Electrophysiology
Electrophysiology was performed on coronal sections from
mice 4–6 weeks old. Detailed information is provided in
Supplement 1.
DARPP-32 Phosphorylation
Striatal protein lysates from mice 38–40 days old were used to
determine DARPP-32 (dopamine- and adenosine monophos-
phate–regulated phosphoprotein of 32 kDa) phosphorylation
levels. Detailed information is provided in Supplement 1.96 Biological Psychiatry July 15, 2015; 78:95–106 www.sobp.org/jourStatistics
Sets of data are presented by mean values and SEM. When
comparing two data sets, an unpaired two-tailed Student t test
was used. A paired Student t test was used when comparing
the effect of a drug with the effect of saline in the same animal.
RESULTS
Hyperlocomotion, Reduced Response Habituation,
and Impaired Nesting Behavior in ACC Mice
We noted altered behavior in ACC mice, which lack ADF
systemically and n-cofilin specifically in the adult telencepha-
lon (16,20). The mice appeared more active compared with
controls or single mutants, for example, on opening of the
cage and removal of nest material (Supplemental Video S1 in
Supplement 2). In contrast to control or single mutants, which
rapidly adapted to the new situation, ACC mice showed
increased activity levels 10 min after opening the cage
(Supplemental Video S2 in Supplement 3).
Beginning at postnatal day 32, home cage activity was
strongly increased in male ACC mice (Figure 1A). Activity
counts at postnatal day 39 amounted to 182% of control
levels (Figure S1A in Supplement 1). Activity was increased in
ACC mice during the night (light off) but not during the day
(Figure 1B; Figure S1A in Supplement 1). Increased activity
during the night resulted from less resting time and increased
numbers and amplitudes of activity peaks (Figure S1B–D in
Supplement 1). Very similar results were obtained from female
mice (data not shown). No changes were observed in single
mutants.
When testing for activity in the open field for 1 hour,
horizontal activity (locomotion) of male ACC mice was
increased fourfold (Figure 1C). Conversely, vertical activity
(rearing) was unchanged in ACC mice (data not shown).
Although locomotion was unchanged in ADF mutants, it was
increased by 35% in n-cofilin mutants. Plotting locomotion
over time revealed increased levels in ACC mice during the
entire recording period (Figure 1D). In contrast to control mice
and single mutants, which habituated to the novel environment
and showed reduced locomotion during the last (12th) 5-min
interval compared with the first interval, locomotion in ACC
mice did not differ between both intervals (Figure S1E in
Supplement 1). Very similar results were obtained in female
mice (data not shown).
Apart from their hyperlocomotion, ACC mice were indis-
tinguishable by observation alone from control mice or single
mutants. They appeared healthy and showed normal posture
and grooming behavior. The ACC mice did not display stereo-
typy or any other bizarre behavior, such as circling, waltzing,
repetitive sniffing, or vertical leaping. Also, the mice did not
display tremors or any obvious motor impairment. However,
we noted impaired nesting behavior of ACC mice. After 24
hours of single housing, all tested control mice or single
mutants had organized the bedding material into a nest,
whereas none of the four ACC mice tested did so (Figure 1E).
Taken together, ACC mice showed strongly increased
locomotion in familiar and novel environments, but, apart fromnal
Figure 1. Increased locomotion
and impaired nesting behavior in dou-
ble mutant (ACC) mice. (A) Beginning
at postnatal day 32, ACC mice, but
not actin-depolymerizing factor (ADF;
n 5 6) or n-cofilin single mutants,
showed increased locomotion in
home cages (control [CTR], n 5 14;
n-cofilin, n 5 8; ADF, n 5 6; ACC, n 5
9). Asterisks and ns, CTR-ACC com-
parison. (B) Activity plots at hourly
intervals revealed increased activity
of postnatal day 39 ACC mice during
the night (gray box), but not during the
day. (C) In the open field, locomotion
was increased fourfold in ACC mice
(CTR, 165.1 6 12.6 m, n 5 10; ACC,
662.2 6 99.0 m, n 5 9; p # .001).
Although locomotion was also inc-
reased by 35% in n-cofilin mutants
(223.0 6 21.8 m, n 5 10; p # .05), it
was unchanged in ADF mutants
(165.9 6 13.1 m, n 5 7; p 5 .964).
(D) Locomotion plots in 5-min inter-
vals revealed enhanced locomotion of
ACC mice during the entire recording
period. Black asterisks, CTR-ACC
comparison; gray asterisks and ns,
CTR-n-cofilin comparison. (E) After
24 hours of single housing, CTR mice
and ADF and n-cofilin mutants orga-
nized bedding material into a nest,
whereas ACC mice did not do so.
ns, not significant; *p # .05; **p #
.01; ***p # .001.
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tion was unchanged in ADF mutants but slightly increased in
n-cofilin mutants when exposed to a novel environment. The
ACC mice, but not the single mutants, showed impaired
nesting behavior and reduced response habituation to novelty.
Normal Locomotion in ACC Mice on Blockade of
Dopamine Transmission
Hyperlocomotion is often associated with impaired dopamine
function (23–27). To test whether this association also held
true for ACC mice, we analyzed locomotion on modulation of
dopamine transmission (Figure 2A). Injection of the D1-like
dopamine receptor antagonist SCH23390 reduced locomotion
in all groups (Figure 2B). The reduction was much stronger in
ACC mice compared with control mice (control, 270.9 6 6.3 m,
n 5 11; ACC, 2568.0 6 41.7 m, n 5 5; p # .001) (Figure S2A
in Supplement 1). After SCH23390 treatment, locomotion did
not differ between the four groups. Similarly, blocking D2-likeBiologicdopamine receptors by haloperidol reduced locomotion in
ACC mice to a much greater degree than it did in control
mice (control, 243.0 6 6.8 m, n 5 10; ACC, 2568.3 6 82.6 m,
n 5 5; p # .001) (Figure 2C and Figure S2B in Supplement 1).
These findings strongly suggest that increased locomotion in
ACC mice is due to impaired dopamine function. The scenario
would be consistent with elevated dopamine activity or
increased dopamine responsiveness.
Calming Effect of Psychostimulants in ACC Mice
To test whether dopamine responsiveness was changed in
ACC mice, we blocked DAT, which removes dopamine from
the synaptic cleft and terminates dopamine activity (23).
Cocaine, a nonselective monoamine reuptake inhibitor,
increased locomotion by 180% in control mice (Figure 2D;
Figure S2C in Supplement 1). Conversely, it reduced locomo-
tion by 34% in ACC mice. Likewise, the selective DAT inhibitor
vanoxerine tripled locomotion in control mice but reducedal Psychiatry July 15, 2015; 78:95–106 www.sobp.org/journal 97
Figure 2. Blockade of dopamine
receptors and dopamine transporter
normalized locomotion in double
mutant (ACC) mice. (A) Scheme of
pharmacobehavioral experiments. On
vehicle injection, locomotion was
recorded for 60 min in the open field.
Thereafter, mice were kept in their
home cages for 60 min before drugs
were injected, and locomotion was
scored for another 60 min in the open
field. (B) Blockade of D1-like dopa-
mine receptor by SCH23390 reduced
locomotion in all groups compared
with saline (marked by asterisks
directly above the SCH23390 bars;
control [CTR], 127.9 6 5.0 m vs. 57.0
6 6.0 m, n 5 11, p # .001; n-cofilin,
190.6 6 17.7 m vs. 61.9 6 3.9 m, n 5
6, p # .001; actin depolymerizing
factor [ADF], 129.5 6 5.6 m vs. 44.3
6 6.2 m, n 5 8, p # .001; ACC, 643.3
6 47.1 m vs. 75.3 6 19.1 m, n 5 5, p
# .001). With SCH23390 treatment,
locomotion of mutant mice was simi-
lar to CTR mice (n-cofilin, p 5 .579;
ACC, p 5 .251). (C) Likewise, block-
ade of D2-like dopamine receptors by
haloperidol reduced locomotion in all
groups (CTR, 119.9 6 9.3 m vs. 76.9
6 7.8 m, n 5 10, p # .01; n-cofilin,
186.5 6 8.6 m vs. 96.7 6 15.3 m, n 5
5, p # .001; ADF, 110.4 6 16.9 m vs.
69.5 6 6.1 m, n 5 8, p # .001; ACC,
618.4 6 74.8 m vs. 50.1 6 12.2 m, n
5 5, p # .05). With haloperidol treat-
ment, locomotion of mutant mice was
similar to CTR mice (n-cofilin, p 5
.217; ACC, p 5 .076). (D) Cocaine
treatment increased locomotion in
CTR mice and single mutants (CTR,
132.4 6 17.0 m vs. 371.9 6 42.1 m, n
5 8, p # .01; n-cofilin, 197.4 6 17.3
m vs. 401.9 6 27.0 m, n 5 9, p #
.001; ADF, 133.4 6 24.9 m vs. 477.3
6 48.4 m, n 5 6, p # .001). In
contrast, cocaine reduced locomotion
in ACC mice (620.7 6 55.0 m vs.
413.2 6 39.7 m, n 5 5, p # .05). With
cocaine treatment, locomotion of
mutant mice was similar to CTR mice
(n-cofilin, p 5 .548; ACC, p 5 .520).
(E) Dopamine transporter inhibition by
vanoxerine increased locomotion in
CTR mice and single mutants (CTR,
106.3 6 9.7 m vs. 318.4 6 45.8 m, n
5 10, p # .01; n-cofilin, 187.3 6 17.5
m vs. 266.76 29.7 m, n 5 9, p # .05;
ADF, 128.2 6 14.6 m vs. 320.6 6
30.6 m, n 5 7, p # .05). In contrast,
vanoxerine reduced locomotion in
ACC mice (664.6 6 25.6 m vs. 157.9
6 15.2 m, n 5 5, p # .001). On
vanoxerine injection, locomotion was
similar to CTR mice in n-cofilin
mutants (p 5 .369) but reduced in
ACC mice (p # .05). (F) Compared
with CTR mice, phosphorylation
of DARPP-32 (dopamine- and ade-
nosine monophosphate–regulated
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Supplement 1). With vanoxerine treatment, locomotion in ACC
mice was similar to locomotion in nontreated control mice.
These data demonstrate that increased dopamine activity, and
not increased dopamine responsiveness, is responsible for
augmented locomotion in ACC mice. This conclusion is further
supported by increased phosphorylation levels of DARPP-32
in the striatum of ACC mice (Figure 2F). DARPP-32 is a protein
phosphatase inhibitor that is highly expressed in striatal
medium spiny neurons (28) and becomes phosphorylated at
threonine 34 in response to dopamine (29).
ADHD Medication Normalizes Locomotion in ACC
Mice
Hyperlocomotion and calming effects of psychostimulants are
hallmarks of ADHD (1). The dopamine/norepinephrine reuptake
inhibitor methylphenidate is widely used for ADHD treatment
and normalizes locomotion in ADHD mouse models
(1,4,27,30,31). We analyzed whether methylphenidate has
similar effects in ACC mice. At a high concentration (20.0
mg/kg body weight), methylphenidate increased locomotion
2.3-fold in control mice but reduced locomotion by 70% in
ACC mice (Figure 2G; Figure S2E in Supplement 1). At a lower
concentration (2.0 mg/kg body weight), methylphenidate
reduced locomotion by 74% in ACC mice (Figure 2H). How-
ever, it did not affect locomotion in control mice. In both
experiments, methylphenidate reduced locomotion in ACC
mice to levels similar to nontreated control mice.
Impaired Working Memory in ACC Mice
We noted altered exploratory behavior of ACC mice in the
Y-maze. Compared with control mice, the relative number of
alternate arm returns was 1.6-fold increased in ACC mice,
whereas the relative numbers of spontaneous alternation
performances or same arm returns were unchanged
(Figure 3A). No such changes were noted when comparing
single mutants with control mice. Altered exploratory behavior
of ACC mice in the Y-maze suggests impaired working memory
(32). To study working memory in an independent approach, we
tested the mice on an eight-arm radial maze using a win-shift
rule (33). Food-deprived mice were allowed to explore the maze
for a maximum of 10 min or until all baits were eaten. Only the
first entry into each arm was , and every further visit was
counted as working memory error (WME). In the first trial, the
performance was equally poor in control and ACC mice as
deduced from similar WME numbers, WME/total arm visit
ratios, and numbers of correct entries before the first WME
(Figure 3B–D). As training proceeded, control mice improved
and ultimately performed better in the fifth trial than in the first
trial. No such improvement was present in ACC mice. In the fifthphosphoprotein of 32 kDa) at threonine 34 (pDARPP-32) was increased in the s
unchanged. Lysates from three CTR and ACC mice are shown. β-Tubulin was used
increased locomotion in CTR mice and single mutants (CTR, 115.76 10.7 m vs. 39
5 10, p # .01; ADF, 108.8 6 6.9 m vs. 314.8 6 42.0 m, n 5 7, p # .05). In contrast
6 19.4 m, n 5 5, p # .01). Compared with CTR mice, locomotion was reduced in
lower concentration (2 mg/kg body weight), methylphenidate reduced locomotion i
alter locomotion in CTR mice or single mutants (CTR, 149.7 6 13.1 m vs. 144.66
.069; ADF, 135.0 6 12.3 m vs. 106.5 6 17.6, n 5 6, p 5 .213). With methylphenida
5 .572; ACC, p 5 .874). BW, body weight; DMSO, dimethyl sulfoxide; ns, not sig
Biologictrial, performance of ACC mice was weaker compared with
control mice; WME numbers and WME/total arm visit ratio were
increased by 260% and 135%, respectively, and the number of
correct entries before the first WME was reduced by 32%.
Conversely, single mutants performed similarly to control mice
throughout the experiment. Working memory was intact in
single mutants but impaired in ACC mice.
ACC Mice Display Impulsive Behavior That Is
Rescued by Methylphenidate
ACC mice also behaved differently from control mice or single
mutants in the elevated plus maze. All control mice or single
mutants remained on the maze for the entire testing period
(300 sec). However, 89% of ACC mice jumped off the 0.5 m
high maze (Figure 4A), reducing the average retention time on
the maze to 111.2 6 32.2 sec (Figure 4B). Of the nine tested
ACC mice, three remained on the maze for a minimum of 180
sec, such that we could analyze their exploratory behavior
within this time frame. Control mice predominantly visited
closed arms of the elevated plus maze, and their relative
distance on closed arms was higher than on open arms
(Figure 4C–D). Conversely, ACC mice visited open arms more
often, and the relative distance was longer on open than on
closed arms. Exploratory behavior of single mutants did not
differ from behavior of control mice.
In another cohort of ACC mice, we tested whether meth-
ylphenidate normalized behavior in the elevated plus maze. On
methylphenidate injection (2.0 mg/kg body weight), all control
mice or single mutants remained on the maze for 300 sec and
showed a clear preference for the closed arms, very similar to
nontreated mice (Figure 4E,F). Methylphenidate almost
doubled the retention time of ACC mice on the maze
(Figure 4B). Of 15 ACC mice, 5 remained on the maze for
300 sec, and 9 remained for a minimum of 180 sec (Figure 4A).
In contrast to nontreated ACC mice, methylphenidate-treated
ACC mice showed no preference for open arms; the treated
ACC mice visited closed and open arms equally often, and the
relative distance did not differ between closed and open arms.
These data reveal an impulsive behavior in ACC mice that is
partially rescued by methylphenidate.
N-Cofilin Is Deleted in Only a Small Fraction of
Dopamine Neurons in Substantia Nigra Pars
Compacta
The present data are consistent with increased activity of
dopamine neurons in the substantia nigra pars compacta (SNc)
that innervate striatal medium spiny neurons (34). In ACC mice,
n-cofilin is deleted in a tissue-specific manner controlled by the
expression of a CaMKII-Cre transgene (21). We next tested
whether CaMKII-Cre is active in SNc dopamine neurons. To dotriatum of ACC mice. Conversely, total DARPP-32 (tDARPP-32) levels were
as a loading control. (G) Injection of methylphenidate (20 mg/kg body weight)
1.36 27.7 m, n 5 8, p # .01; n-cofilin, 165.2 6 14.1 m vs. 282.46 17.0 m, n
, methylphenidate reduced locomotion in ACC mice (552.8 6 71.5 m vs. 163.1
n-cofilin mutants and in ACC mice (n-cofilin, p # .05; ACC, p # .01). (H) At a
n ACC mice (535.5 6 32.5 m vs. 138.9 6 33.8, n 5 5, p # .001), but it did not
19.0, n 5 9, p 5 .828; n-cofilin, 192.36 15.5 m vs. 141.2 6 12.7, n 5 10, p 5
te treatment, locomotion of mutant mice was similar to CTR mice (n-cofilin, p
nificant; *p # .05; **p # .01; ***p # .001.
al Psychiatry July 15, 2015; 78:95–106 www.sobp.org/journal 99
Figure 3. Impaired working mem-
ory in double mutant (ACC) mice. (A)
In ACC mice, the relative number of
alternate arm returns (AAR) was
increased during a 5-min testing per-
iod in the Y-maze (control [CTR],
31.6% 6 3.6%, n 5 10; ACC, 50.7%
6 4.8%, n 5 7; p # .01), whereas the
relative numbers of spontaneous
alternation performances (SAP) and
same arm returns (SAR) were
unchanged (SAP—CTR, 59.9% 6
3.0%; ACC, 44.8% 6 8.1%; p 5
.065; SAR—CTR, 8.5% 6 3.5%;
ACC, 4.4% 6 3.5%; p 5 .438). Con-
versely, n-cofilin and ADF mutants
displayed normal exploratory behavior
in the Y-maze. (B) Compared with
CTR mice, the numbers of working
memory errors (WME) were increased
in trial 3 to trial 5 in ACC mice in the
eight-arm radial maze (CTR—trial 3,
3.1 6 1.2; trial 4, 3.1 6 1.2; trial 5, 2.3
6 .6, n 5 8; ACC—trial 3, 17.8 6 3.0,
p # .001; trial 4, 10.0 6 3.1, p # .05;
trial 5, 8.3 6 2.2, p # .001, n 5 6). The
WME numbers were unchanged in the
single mutants. (C) Ratios of WME to
total arm visit (WME/total ratio) were
increased in ACC mice in trial 3 and
trial 5 compared with CTR mice (CTR
—trial 3, .23 6 .07; trial 5, .20 6 .05;
ACC—trial 3, .686 .04, p# .001; trial 5,
.47 6 .07, p # .01). In trial 4, the
increase in WME/total ratio did not
reach statistical significance (CTR, .24 6 .07; ACC, .49 6 .09; p 5 .056). (D) Likewise, the numbers of correct entries before first WME were decreased in ACC
mice in trial 3 and trial 5 (CTR—trial 3, 6.1 6 .7; trial 5, 6.3 6 .5; ACC—trial 3, 3.2 6 .6, p # .05; trial 5, 4.3 6 .7, p # .05). The decrease in trial 4 did not reach
statistical significance (CTR, 5.8 6 .6; ACC, 4.0 6 .4; p 5 .054). The WME/total ratios and numbers of correct entries before first WME were unchanged in
single mutants. (B–D) Asterisks and ns, CTR-ACC comparison; ns, not significant; *p # .05; **p # .01; ***p # .001.
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that express beta-galactosidase on Cre activation (22). X-Gal
staining of double transgenic mice confirmed broad Cre activity
in the telencephalon of CaMKII-Cre mice (Figure 5A–C), including
the striatum, in which Cre was active in 84.2% 6 2.4% of all
neurons (n 5 6 sections from 3 mice) (Figure 5D). Conversely,
only sparse beta-galactosidase expression was detectable in
SNc (Figure 5B,C). Immunostaining against beta-galactosidase
and tyrosine hydroxylase confirmed the absence of Cre activity
from most SNc dopamine neurons (94.5% 6 1.2%, n 5 5
sections from 3 mice) (Figure 5E,F). From these data, we
conclude that altered dopamine activity in ACC mice is not
caused by cell autonomous defects.
Altered Density and Morphology of Striatal
Excitatory Synapses in ACC Mice
Medium spiny neurons are inhibitory projection neurons that
amount to 95% of all neurons in the striatum (35). Medium
spiny neurons integrate glutamatergic inputs from the cerebral
cortex and thalamus as well as dopaminergic inputs from SNc,
and they play a key role in controlling locomotion (34). A
reciprocal modulation of dopamine and glutamate has been
described in the striatum, where glutamate facilitates dopa-
mine release (36,37). Deregulation of actin dynamics can
enhance glutamate release in striatal excitatory synapses,100 Biological Psychiatry July 15, 2015; 78:95–106 www.sobp.org/jouaccompanied by alterations in synapse ultrastructure (38). To
assess whether impaired ADF/cofilin activity causes similar
alterations, we first quantified the density of striatal excitatory
synapses by electron microscopy and found it decreased by
16% in ACC mice (Figure 6). The morphology of striatal
excitatory synapses was altered in ACC mice—the presynap-
tic bouton area was increased by 33%, the dendritic spine
area was increased by 39%, and the postsynaptic density
length was increased by 21% (Figure 7A–H). Additionally, the
number of docked vesicles per active zone was increased by
17% (Figure 7I), although this effect did not reach statistical
significance (p 5 .083). In contrast to ACC mice, the numbers
of excitatory synapses were unaltered in the striatum of
n-cofilin and ADF mutants, and their morphologies were
grossly preserved except for a slight increase in spine size in
n-cofilin mutants (Figures 6 and 7). Overall, these changes
demonstrated a crucial role of ADF/cofilin for the ultrastructure
of striatal excitatory synapses, which became evident only on
inactivation of both ADF/cofilin proteins.
Blockade of Glutamate Transmission Normalizes
Locomotion in ACC Mice
To test whether the alterations in synapse ultrastructure
may be paralleled by altered glutamate release in the
striatum, we recorded spontaneous excitatory postsynapticrnal
Figure 4. Methylphenidate (MPH)
partially rescued impulsive behavior
in double mutant (ACC) mice. (A)
Relative number of nontreated (w/o
MPH; n 5 9) and MPH-injected (with
MPH; n 5 15) ACC mice that
remained on the elevated plus maze
(EPM) either for the entire duration of
recording (300 sec) or for a minimum
of 180 sec. (B) Average time that
nontreated or MPH-injected ACC
mice remained on the EPM (w/o
MPH, 111.2 6 32.2 sec; with MPH,
205.9 6 26.8 sec; p # .05). (C) During
the first 180 sec of recording, control
(CTR) mice visited closed arms (CA)
more often than open arms (OA) (CA,
85.8% 6 4.6%; OA, 14.2% 6 4.6%;
n 5 9, p # .001), whereas ACC mice
visited CA less often (CA, 28.3% 6
5.9%; OA, 71.7% 6 5.9%; n 5 3, p #
.05). (D) The relative distance in the
CA was much higher than that in the
OA in CTR mice (CA, 87.5% 6 3.8%;
OA, 12.5% 6 3.8%; p # .001). The
opposite was found for ACC mice
(CA, 18.3% 6 3.4%; OA, 81.7% 6
3.4%; p # .01). Single mutants dis-
played unaltered exploratory beha-
vior. (E) Relative numbers of arm
visits on MPH treatment. The CTR
mice visited CA more often (CA,
83.1% 6 3.5%; OA, 16.9% 6 3.5%;
n 5 12, p # .001), whereas CA visits
were similar to OA visits in ACC mice
(CA, 43.4% 6 7.6%; OA, 56.6% 6
7.6%; n 5 9, p 5 .204). (F) Likewise,
relative distance in CA was higher in
CTR mice with MPH treatment (CA,
82.7% 6 9.1%; OA, 17.3% 6 9.1%; p
# .001), whereas in ACC mice, the
relative distances were similar in both
arms (CA, 43.8% 6 8.9%; OA, 56.2%
6 8.9%; p 5 .256). With MPH treat-
ment, exploratory behavior of single
mutants was similar to CTR mice. ns,
not significant; *p # .05; **p # .01;
***p # .001.
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Psychiatrycurrents from patch-clamped medium spiny neurons
(Figure 8A). We found unchanged spontaneous excitatory
postsynaptic current amplitudes in ACC mice, indicative of
normal vesicular glutamate load and postsynaptic sensitivity
(Figure 8B). In contrast, the interevent interval was reduced
by 69% in ACC mice (Figure 8C). Pharmacologic blockade
of glutamate transmission by CNQX, a competitive antago-
nist of alpha-amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid and kainate receptors, strongly reduced the
amplitudes and increased the interevent interval of sponta-
neous excitatory postsynaptic currents recorded from
medium spiny neurons in ACC mice, confirming that spon-
taneous excitatory postsynaptic currents are mediated by
glutamate (data not shown). Together, these dataBiologicademonstrate strongly elevated glutamate release in the
striatum of ACC mice.
We next tested whether the hyperlocomotion in ACC mice
is caused by high glutamate activity. The use of CNQX in
behavioral experiments is impractical because of the massive
disturbances expected from blocking the bulk of fast excita-
tory transmission. We assessed locomotion after injection of
dizocilpine, a noncompetitive antagonist of N-methyl-D-aspar-
tate receptors that colocalize with alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptors (39). Dizocilpine
increased locomotion by 64% in control mice. Conversely, it
reduced locomotion by 66% in ACC mice (Figure 8D; Figure
S2G in Supplement 1). On dizocilpine injection, locomotion of
ACC mice did not differ from nontreated control mice.l Psychiatry July 15, 2015; 78:95–106 www.sobp.org/journal 101
Figure 5. Cell type–specific inactivation of n-cofi-
lin. (A, B) X-gal staining of CaMKII-cre/Rosa26 repor-
ter mice confirmed active Cre in the telencephalon of
adult mice, for instance, in the cerebral cortex (CC),
nucleus caudatus and putamen (CPu) of the striatum,
and hippocampus (HIP). Framed area in (B) is
depicted in (C) at higher magnification. Scale bar 5
500 mm. (C) In the substantia nigra pars compacta
(SNc), only a few neurons showed X-gal staining.
Scale bar 5 500 mm. (D) Double-immunostaining
against beta-galactosidase (βGal; green) and neu-
ron-specific nuclear protein (NeuN; magenta)
revealed active Cre in most CPu neurons. Scale bar
5 100 mm. (E) Double-immunostaining against βGal
(green) and tyrosine hydroxylase (TH; magenta) that
was used as a marker for dopamine neurons in SNc.
Framed area is depicted in (F) at higher magnification.
Scale bar 5 100 mm. (F) Only a small fraction of
dopamine neurons in the SNc expressed βGal (whit-
ish green cells). Scale bar 5 20 mm. cp, cerebral
peduncle; SNr, substantia nigra pars reticulata.
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ACC mice, demonstrating that increased glutamate activity
causes hyperlocomotion in these animals.ACCADF
CTR
DC
E
CTR n-cofilin ADF ACC
ns
*
ns
n-cofilin
Figure 6. Reduced density of striatal excitatory synapses in double
mutant (ACC) mice. (A–D) Representative electron microscopy micrographs
as used for determination of synapse density. Arrows indicate excitatory
synapses. (A, Scale bar 5 200 nm.) (E) In ACC mice, the density of striatal
excitatory synapses was reduced (control [CTR]—.247 6 .011 synapses/
mm2; total analyzed area, 1715.22 mm2 in three mice; ACC—.207 6 .012
synapses/mm2; total analyzed area, 1319.40 mm2 in three mice; p # .05). No
such reduction was seen in n-cofilin or actin depolymerizing factor (ADF)
mutants (n-cofilin—.248 6 .010 synapses/mm2; total analyzed area, 1700.56
mm2 in three mice; p 5 .983; ADF—.265 6 .012 synapses/mm2; total
analyzed area, 1539.30 mm2 in three mice; p 5 .447). Apart from mean
values 6 SEM, the median and the 1%, 25%, 75%, and 99% values are
given in the box plots (same in Figure 7). ns, not significant; *p # .05.DISCUSSION
In the present study, we report abnormal behavior in ACC
mice lacking the actin depolymerizing proteins ADF and
n-cofilin. Increased locomotion, impulsivity, and impaired
working memory were displayed by ACC mice. These defects
were corrected by psychostimulants, resembling the situation
observed in patients with ADHD. We noted markedly
increased glutamate transmission in the striatum that is likely
to be responsible for the deregulation of dopamine in ACC
mice. Normal locomotion on blockade of dopamine or gluta-
mate activity suggests that the ADHD-like phenotype is
caused by elevated glutamate activity and disturbed dopami-
nergic transmission.
By exploiting gene targeted mice, we have unraveled the
relevance of actin depolymerizing proteins of the ADF/cofilin
family for synapse physiology and mouse behavior. We have
shown previously that inactivating n-cofilin in the adult tel-
encephalon impairs postsynaptic plasticity, associative
learning, and anxiety (19,20), whereas synapse physiology
and behavior are preserved in systemic ADF mutants (17). In
the present study, we report neurobehavioral abnormalities
in ACC mice that are not present in single mutants, provid-
ing evidence for overlapping functions of ADF and n-cofilin
in the brain. The neurobehavioral abnormalities in ACC mice
include hyperlocomotion, impulsivity, impaired working
memory, and missing nesting behavior. In ACC mice, hyper-
locomotion was more pronounced in a novel environment
than in a familiar one, indicating increased responses to
novelty. Additionally, ACC mice showed decreased
response habituation to novelty, a trait that is implicated in
attention deficits in humans (40,41). Psychostimulants,
including the ADHD medication methylphenidate, amelio-
rated the behavioral defects in ACC mice. However, meth-
ylphenidate normalized locomotion yet only partially102 Biological Psychiatry July 15, 2015; 78:95–106 www.sobp.org/journal
Figure 7. Altered morphology of
striatal excitatory synapses in double
mutant (ACC) mice. (A–D) Represen-
tative electron microscopy micro-
graphs as used for the analysis of
synapse morphology. b, presynaptic
bouton; d, dendritic spine; arrows
indicate docked vesicles. (A, Scale
bar 5 100 nm.) (E) Box plot showing
enlarged bouton areas in ACC mice
(control [CTR], .261 6 .009 mm2; ACC,
.348 6 .015 mm2; p # .001). No such
alteration was noted in n-cofilin or
actin depolymerizing factor (ADF)
mutants (n-cofilin, .231 6 .009 mm2,
p 5 .071; ADF, .265 6 .010 mm2, p 5
.962). (F, G) Dendritic spine area
(CTR, .111 6 .005 mm2; ACC, .155 6
.008 mm2; p # .001) and length of the
postsynaptic density (PSD). (CTR,
.277 6 .008 mm; ACC, .336 6 .013
mm; p # .001) were also increased in
ACC mice. Dendritic spine area, but
not PSD length, was increased in
n-cofilin mutants (spine area, .130 6
.007 mm2, p # .05; PSD length, .289 6
.009 mm, p 5 .316). No changes were
noted in ADF mutants (spine area,
.101 6 .004 mm2, p 5 .248; PSD
length, .279 6 .007 mm, p 5 .788).
(H) The number of docked vesicles
was increased by 17% in ACC mice
(CTR, 3.55 6 .24 docked vesicles/
active zone, n 5 55/3; ACC, 4.16 6
.25 docked vesicles/active zone, n 5
44/3). However, this increase did not
reach statistical significance (p 5
.083). No such increase was noted
for n-cofilin or ADF mutants (n-cofilin,
3.28 6 .25 docked vesicles/active
zone, 28%, n 5 58/3, p 5 .357;
ADF, 3.460 6 .25 docked vesicles/
active zone, 23%, n 5 50/3, p 5
.804). ns, not significant; *p # .05; ***p
# .001.
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Psychiatryrescued the impulsive behavior of ACC mice in the elevated
plus maze, suggesting that defects in certain neurotrans-
mitter systems or neuronal circuits or both contribute differ-
entially to the behavioral defects. A similar observation has
been made for coloboma mice (42), an established ADHD
model (43,44). Together, the neurobehavioral defects of
ACC mice strongly resemble the symptoms observed in
patients with ADHD (1). The neurobehavioral defects of ACC
mice are very similar to defects described in ADHD mouse
models, including DAT knockout or knockdown mice (4),
GIT1 (G protein–coupled receptor kinase–interacting pro-
tein-1) knockout mice (31), or mice overexpressing casein
kinase 1-δ (CK1δ) (27). Associative learning was impaired in
DAT and GIT1 mutants (31,45), and anxiety was reduced in
CK1δ-overexpressing mice (27), similar to what we reported
previously for n-cofilin mutants (19,20). The behavioral
abnormalities in ACC mice include all hallmarks of ADHD,
suggesting that ACC mice are a valuable tool to study the
mechanisms underlying ADHD.BiologicaHow might inactivation of ADF and n-cofilin cause ADHD?
Human genetics and mouse models suggest dopamine dereg-
ulation as causative for ADHD (3,4). Normal locomotion on
blockade of dopamine receptors revealed a dopamine dereg-
ulation in ACC mice as well. In these mutants, ADF is
systemically deleted, whereas deletion of n-cofilin is controlled
by the expression of a CaMKII-Cre transgene (21). In these
transgenic mice, Cre is not expressed during brain develop-
ment, and expression in adults is largely restricted to the
telencephalon. We found that Cre is not active in most SNc
dopamine neurons, and we can conclude that altered behavior
of ACC mice is not caused by developmental defects and
most likely not caused by impaired function of SNc dopamine
neurons. The fact that Cre expression does not start before
the third postnatal week is likely to be responsible for the
relatively late onset of hyperlocomotion in ACC mice.
How does loss of ADF and n-cofilin lead to a deregulation
of dopamine? Our ultrastructural analyses revealed an altered
density and morphology of striatal excitatory synapses in ACCl Psychiatry July 15, 2015; 78:95–106 www.sobp.org/journal 103
Figure 8. Blockade of glutamate
transmission rescues locomotion in
double mutant (ACC) mice. (A)
Representative traces show sponta-
neous excitatory postsynaptic cur-
rents recorded from striatal medium
spiny neurons of a control (CTR) and
an ACC mouse. (B) Cumulative
curves and mean values (inset) of
spontaneous excitatory postsynaptic
current amplitudes. No difference
was found between CTR and ACC
mice (CTR, 9.91 6 1.01 pA, n 5 8
neurons from 5 mice; ACC, 8.68 6
.72 pA, n 5 7/3; p 5 .175). (C)
Cumulative curves and mean values
(inset) demonstrate a reduction in the
interevent intervals of spontaneous
excitatory postsynaptic currents in
ACC mice (CTR, .688 6 .060 msec;
ACC, .284 6 .035 msec;
p # .001). (D) Injection of the N-
methyl-D-aspartate receptor antago-
nist dizocilpine increased locomotion
in both CTR and single mutants
(CTR, 123.6 6 10.4 m vs. 202.5 6
31.6 m, n 5 10, p # .05; n-cofilin,
200.2 6 15.2 m vs. 303.1 6 37.5 m,
n 5 10, p # .05; ADF, 124.0 6 7.3 m
vs. 245.5 6 39.6 m, n 5 8, p # .01)
but reduced locomotion in ACC mice (498.2 6 37.6 m vs. 171.3 6 61.6 m, n 5 5, p # .01). After treatment, locomotion was comparable between CTR and
ACC mice but slightly increased in n-cofilin mutants. ns, not significant; *p # .05; **p # .01; ***p # .001.
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synapses, together with enlarged presynaptic and postsynap-
tic structures, and elevated synaptic vesicle counts. Synapse
density and morphology were unchanged in ADF mutants, and
spine size was increased in n-cofilin mutants, similar to what
we reported previously for hippocampal synapses (17,20).
However, in contrast to in the hippocampus, synapse density,
bouton size, and postsynaptic density length were unchanged
in the striatum of n-cofilin mutants. This discrepancy could be
explained either by region-specific functions of n-cofilin or by
different levels of Cre activation in both brain regions.
Although Cre was active in only 84% of all striatal neurons,
we found active Cre in .97% of all CA1 pyramidal cells
(M. Wolf, unpublished data, April 4, 2014). In ACC mice, the
structural defects were accompanied by increased striatal
glutamatergic activity in ACC mice, suggesting that ADF and
n-cofilin have a crucial role in the control of synaptic trans-
mission in central excitatory synapses. Glutamate and do-
pamine intimately interact at the level of medium spiny
neurons (34), and the interaction is important for the control
of behavior, including locomotion (46,47). Specifically, gluta-
mate facilitates striatal dopamine release (36,37). It is plausible
that the enhanced glutamate activity in the striatum of ACC
mice facilitates dopamine release and ultimately results in the
observed behavioral defects. In very good agreement with this
idea, we found normalized locomotion on blockade of
N-methyl-D-aspartate receptors in ACC mice. The idea of
altered dopamine activity in ACC mice is further supported by
the phenotypic similarities to DAT mutants (4), in which DAT
inactivation results in a state of “functional hyperdopaminer-
gia” that is responsible for behavioral impairment (48).104 Biological Psychiatry July 15, 2015; 78:95–106 www.sobp.org/jouThe activity of inhibitory neurons was unchanged in ACC
mice, as indicated by unchanged amplitudes and interevent
intervals of miniature inhibitory postsynaptic currents recorded
from CA1 pyramidal cells (A. Görlich, PhD, unpublished data,
April 4, 2014), a finding that is in very good agreement with the
absence of Cre activity in inhibitory neurons of CaMKII-Cre
transgenic mice (21). In ACC mice, the balance between
excitation and inhibition (E/I balance) is shifted toward excita-
tion. Maintenance of the E/I balance is crucial for the
functionality of the brain (49), and E/I imbalance is postulated
to underlie the pathogenesis of neuropsychiatric disorders,
such as autism, schizophrenia or Tourette’s syndrome (50–52).
More recent studies have associated E/I imbalance with ADHD
(31,53–55). In these studies, it is suggested that reduced
neuronal inhibition contributes to ADHD pathogenesis. Our
data not only support this idea but further suggest that an E/I
imbalance can be causative for ADHD and that ADHD can
result from increased excitation.
In conclusion, our study is the first to link ADHD to actin
dynamics. Use of ACC mice allows novel insights into the
mechanisms that cause ADHD. Our data also allow us to
hypothesize that mutations in actin regulatory proteins con-
tribute to the etiology of ADHD in humans.ACKNOWLEDGMENTS AND DISCLOSURES
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